Molecular and Clinical Characterization of PD-1 in Breast Cancer Using Large-Scale Transcriptome Data

Molecular and Clinical Characterization of PD-1 in Breast Cancer Using Large-Scale Transcriptome Data

Despite the impressive impact of PD-1 (programmed cell death protein 1)-targeted cancer immunotherapy, a great part of patients with cancer fail to respond. PD-1 impact on immune cells in addition to T cells, and the synergistic role of PD-1 with other immune modulators remain largely unknown. To fi...

Full description

Bibliographic Details
Main Authors: Qiang Liu, Ran Cheng, Xiangyi Kong, Zhongzhao Wang, Yi Fang, Jing Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Immunology
Subjects:
breast cancer
cancer immunotherapy
PD-1
immune response
inflammatory activity
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2020.558757/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2020.558757/full

Similar Items